Quick Answer
NP Life Sciences Health Industry Group Inc. reported Operating Income of -$690.00 for fiscal year 2023.
NP Life Sciences Health Industry Group Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2023 | -$690.00 | +96.3% |
| 2022 | -$18.9K | +71.3% |
| 2021 | -$65.7K | +49.9% |
| 2020 | -$131.1K | -20.4% |
| 2019 | -$108.9K | -421.2% |
| 2018 | -$20.9K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | -$37.4K | -588.3% | -152.4% |
| June 30, 2023 | $71.4K | +6528.8% | +5727.9% |
| March 31, 2023 | $1.2K | +103.9% | +122.5% |
| September 30, 2022 | -$5.4K | +73.9% | -605.1% |
| June 30, 2022 | $1.1K | +102.0% | +103.5% |
| March 31, 2022 | -$31.1K | -28.2% | -49.2% |
| September 30, 2021 | -$20.8K | +18.7% | +60.5% |
| June 30, 2021 | -$52.7K | +1.7% | -117.5% |
- NP Life Sciences Health Industry Group Inc. showed an increase of +96.3% in Operating Income compared to the prior fiscal year.
- Over the 2018–2023 period, NP Life Sciences Health Industry Group Inc.’s operating income has grown by 96.7% (from -$20.9 thousand to -$690.00).
- The most recent figure is from NP Life Sciences Health Industry Group Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on April 16, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: